Rudzinski Marcelo, Wong Tak-Pan, Saragovi H Uri
Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.
J Neurobiol. 2004 Feb 15;58(3):341-54. doi: 10.1002/neu.10293.
Open angle glaucoma is defined as a progressive and time-dependent death of retinal ganglion cells concomitant with high intraocular pressure, leading to loss of visual field. Because neurotrophins are a family of growth factors that support neuronal survival, we hypothesized that quantitative and qualitative changes in neurotrophins or their receptors may take place early in ocular hypertension, preceding extensive cell death and clinical features of glaucoma. We present molecular, biochemical, and phenotypic evidence that significant neurotrophic changes occur in retina, which correlate temporally with retinal ganglion cell death. After 7 days of ocular hypertension there is a transient up-regulation of retinal NGF, while its receptor TrkA is up-regulated in a sustained fashion in retinal neurons. After 28 days of ocular hypertension there is sustained up-regulation of retinal BDNF, but its receptor TrkB remains unchanged. Throughout, NT-3 levels remain unchanged but there is an early and sustained increase of its receptor TrkC in Müller cells but not in retinal ganglion cells. These newly synthesized glial TrkC receptors are truncated, kinase-dead isoforms. Expression of retinal p75 also increases late at day 28. Asymmetric up-regulation of neurotrophins and neurotrophin receptors may preclude efficient neurotrophic rescue of RGCs from apoptosis. A possible rationale for therapeutic intervention with Trk receptor agonists and p75 receptor antagonists is proposed.
开角型青光眼被定义为视网膜神经节细胞进行性且随时间发展的死亡,并伴有高眼压,进而导致视野丧失。由于神经营养因子是一类支持神经元存活的生长因子,我们推测在眼压升高早期,在广泛的细胞死亡和青光眼临床特征出现之前,神经营养因子或其受体可能会发生数量和质量上的变化。我们提供了分子、生化和表型证据,表明视网膜中发生了显著的神经营养变化,这些变化与视网膜神经节细胞死亡在时间上相关。眼压升高7天后,视网膜神经生长因子(NGF)短暂上调,而其受体酪氨酸激酶A(TrkA)在视网膜神经元中持续上调。眼压升高28天后,视网膜脑源性神经营养因子(BDNF)持续上调,但其受体酪氨酸激酶B(TrkB)保持不变。在此期间,神经营养因子-3(NT-3)水平保持不变,但其受体酪氨酸激酶C(TrkC)在米勒细胞中早期且持续增加,而在视网膜神经节细胞中则不然。这些新合成的胶质细胞TrkC受体是截短的、激酶失活的异构体。视网膜p75的表达在第28天后期也增加。神经营养因子和神经营养因子受体的不对称上调可能会妨碍对视网膜神经节细胞凋亡的有效神经营养性挽救。本文提出了用Trk受体激动剂和p75受体拮抗剂进行治疗干预的可能理论依据。